How Successful Investors Get RICH

Learn everything you need to know in 'The Canadian Guide on How to Invest in Stocks Successfully' for FREE from The Successful Investor.

How to Invest In Stocks Guide: Find 10 factors that make your investments safer and stronger.

 I consent to receiving information from The Successful Investor via email. I understand I can unsubscribe from these updates at any time.

Topic: Cannabis Investing

Pharmacy chain moves closer to selling cannabis

Read Next Article →

Cannabis-Connected

Health Canada recently awarded this chain of drugstores a licence to produce medical cannabis. While the business doesn’t plan to grow the plant itself, that licence is a key step in its quest to distribute medical cannabis through its pharmacies. Completing the second step is even more important and could set the chain up to directly benefit from the growing number of Canadians using cannabis medicinally.


YOUR MARIJUANA I.Q.

Think you know all about Marijuana and Investing?

Test your knowledge with our fun and easy Marijuana Investment Quiz.

Do so today and be a whiz!

LOBLAW COMPANIES LTD., $64.24, symbol L on Toronto (Shares outstanding: 374.6 million; Market cap: $24.1 billion; www.loblaw.ca) operates 1,083 supermarkets under a variety of banners: Loblaw, Zehrs, Provigo, Real Canadian Superstore and No Frills.

In March 2014, the company purchased the Shoppers Drug Mart chain for $12.3 billion in cash and shares. Shoppers now operates 1,335 drug stores across Canada.

Loblaw feels its Shoppers Drug Mart stores give it a strong platform to profit from the legalization of cannabis on October 17, 2018. That’s because their pharmacy operations have experience distributing controlled substances and counselling customers about their effects.

Health Canada recently awarded Shoppers Drug Mart a licence to produce medical cannabis. Shoppers does not plan to grow the drug, but has signed supply deals with several major cannabis producers, including Tilray, Aurora Cannabis and Aphria.

This licence is the first step in Shoppers’s plan to distribute medical cannabis through its pharmacies. The second step is a sales licence, which would let it sell those products to patients over the Internet.

In addition, Loblaw is looking at selling cannabis though dedicated stores separate from the Shoppers chain.

The company has applied for a licence to sell recreational cannabis in Newfoundland and Labrador. If successful, it would sell the drug in its existing tobacco shops next to its supermarkets.

The province plans to licence around 45 cannabis stores; 10 of Loblaw’s locations made the initial list of qualified applicants.

Shoppers has also formed an alliance with insurance provider Manulife Financial Corp., Toronto symbol MFC, which is now offering medical cannabis insurance coverage. Manulife clients that qualify for cannabis treatments can now consult with a Shoppers pharmacist to determine the appropriate strains and how to safely take it.

Meantime, Loblaw recently announced a new plan that should unlock some of its hidden value.

It will transfer its 61.6% stake in Choice Properties REIT, Toronto symbol CHP.UN, to its parent company George Weston Ltd., Toronto symbol WN. In exchange, Loblaw shareholders will receive 0.135 of a Weston common share for each share they hold. They will not have to pay capital gains taxes until they sell their new Weston shares.

Weston (which currently owns 50.1% of Loblaw) also holds 3.8% of Choice. Following the transfer, it will own 65.4% of the REIT. As well, Loblaw shareholders will hold 16.8% of Weston’s shares.

Loblaw plans to maintain its current annual dividend rate of $1.18 a share (which yields 1.8%) after the exchange. In addition, Weston will raise its quarterly dividend by 5% to $0.515 a share. The new annual rate of $2.06 yields 2.3%.

If you combine those two payments, the total of $1.46 a share represents a 23.7% increase over Loblaw’s current dividend. The deal also lets the company focus exclusively on its retail businesses.

Loblaw shareholders, excluding Weston, will vote on the deal on October 18, 2018. If they approve, the company expects to complete the transaction by the end of this year.

Loblaw is a buy.

Comments

Tell Us What YOU Think

You must be logged in to post a comment.

Please be respectful with your comments and help us keep this an area that everyone can enjoy. If you believe a comment is abusive or otherwise violates our Terms of Use, please click here to report it to the administrator.